Feasibility of dendritic cell-based vaccine against glioblastoma by using cytoplasmic transduction peptide (CTP)-fused protein antigens combined with anti-PD1

Recent clinical trials utilizing antigen-pulsed dendritic cells (DCs) have demonstrated increased survival of vaccinated cancer patients. Besides, the cytoplasmic transduction peptide (CTP) not only has an excellent transcellular efficiency but also shows a strong tendency to remain in the cytoplasm...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Hum Vaccin Immunother
Main Authors: Kim, Young-Hee, Tran, Thi-Anh-Thuy, Duong, Thi-Hoang-Oanh, Jung, Shin, Kim, In-Young, Moon, Kyung-Sub, Jang, Woo-Youl, Lee, Hyun-Ju, Lee, Je-Jung, Jung, Tae-Young
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2020
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7734070/
https://ncbi.nlm.nih.gov/pubmed/32401608
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2020.1732165
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados